Amphidinolide E
C30H44O6 — CID 101181995
Data last refreshed: (MolForge compound catalog, from PubChem)
About Amphidinolide E
Amphidinolide E (PubChem CID 101181995) has the molecular formula C30H44O6 and a molecular weight of 500.68 g/mol. Its IUPAC name is (1S,2R,3R,6R,7Z,9Z,11R,12R,13Z,17S)-2,11,12-trihydroxy-6-methyl-3-[(2R,5E)-8-methyl-4-methylidenenona-5,8-dien-2-yl]-4,20-dioxabicyclo[15.2.1]icosa-7,9,13-trien-5-one.
Molecular Properties
| Compound Name | Amphidinolide E |
|---|---|
| PubChem CID | 101181995 |
| Molecular Formula | C30H44O6 |
| Molecular Weight | 500.68 g/mol |
| Exact Mass | 500.31 |
| IUPAC Name | (1S,2R,3R,6R,7Z,9Z,11R,12R,13Z,17S)-2,11,12-trihydroxy-6-methyl-3-[(2R,5E)-8-methyl-4-methylidenenona-5,8-dien-2-yl]-4,20-dioxabicyclo[15.2.1]icosa-7,9,13-trien-5-one |
| SMILES | C=C(C)C/C=C/C(=C)C[C@@H](C)[C@H]1OC(=O)[C@H](C)/C=C\C=C/[C@@H](O)[C@H](O)/C=C\CC[C@H]2CC[C@H](O2)[C@H]1O |
| InChI | InChI=1S/C30H44O6/c1-20(2)11-10-12-21(3)19-23(5)29-28(33)27-18-17-24(35-27)14-7-9-16-26(32)25(31)15-8-6-13-22(4)30(34)36-29/h6,8-10,12-13,15-16,22-29,31-33H,1,3,7,11,14,17-19H2,2,4-5H3/b12-10+,13-6-,15-8-,16-9-/t22-,23-,24+,25-,26-,27+,28-,29-/m1/s1 |
| InChIKey | JGRAKHHMDYESEH-CRVPJHTMSA-N |
| XLogP | 4.73 |
| TPSA | 96.22 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.68 |
| LogP ≤ 5 | 4.73 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 101181995 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.